BCMA-Targeted Treatments in Multiple Myeloma: Novel Approaches and Recent Advances

Program Description

B-cell maturation antigen (BCMA) is overexpressed in multiple myeloma (MM) and has emerged as a viable therapeutic target. With multiple BCMA-targeted constructs approved and under investigation in the MM treatment landscape, it will be important for pharmacists to identify patients with MM who are candidates for BCMA-targeted agents based on patient- and disease-related factors. Though BCMA-targeted therapies may likely improve outcomes for patients with MM, the associated resources necessary for planning, administration, monitoring, and costs present additional challenges for patients, pharmacies, and payers. This article will explore ongoing and evolving data surrounding the use of BCMA-targeted therapies in MM that managed care pharmacists can utilize to plan appropriate resources, develop eligibility criteria, and promote cost-effective treatment within their organizations.

Target audience: Oncology pharmacists and managed care pharmacists

Type of activity: Application
Release date: August 8, 2022
Expiration date: February 29, 2024

Time to complete activity: 2.0 hours
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Determine the biology of B-cell maturation antigen (BCMA) in multiple myeloma (MM) and the common BCMA-targeted treatment modalities.
• Analyze the clinical data for recently approved and emerging BCMA-targeted agents in the treatment of MM.
• Explore the economic burden of MM and the cost-effective strategies for the use of BCMA-targeted therapies.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEU) under the ACPE universal activity number 0290-0000-22-333-H01-P. The activity is available for CE credit through February 29, 2024.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Ryan Haumschild, PharmD, MS, MBA, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Evelina Kolychev, PharmD, BCOP; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

Ashley Ann Walsh, PharmD, has no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms